HNSA — Hansa Biopharma AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Hansa Biopharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	601	1,378	889	1,496	732
Net Total Accounts Receivable
Net Total Receivables	11.7	10.1	32.3	65	91.8
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	616	1,393	942	1,605	855
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15.1	9.7	41.7	35.8	27.1
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	664	1,434	1,013	1,687	1,018
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	94.5	114	171	265	321
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	101	192	255	1,084	1,186
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	563	1,242	758	603	-168
Total Liabilities & Shareholders' Equity	664	1,434	1,013	1,687	1,018
Total Common Shares Outstanding